NEW YORK (GenomeWeb) – An international, public-private group led by Thomas Jefferson University is offering a collaborative training program designed to preemptively combat the potential threat of an Ebola virus epidemic in Ivory Coast.

The four-week training program will take place in the laboratory of Matthias Schnell, professor of microbiology and immunology at TJU, whose research team is developing an Ebola virus vaccine that is expected to move into clinical trials in mid-2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.